share_log

B of A Securities Maintains Underperform on CureVac, Lowers Price Target to $8

Benzinga ·  Aug 21, 2023 11:38

B of A Securities analyst Geoff Meacham maintains CureVac (NASDAQ:CVAC) with a Underperform and lowers the price target from $10 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment